Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 161-180 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 161 | Antaris Inc. lowweak | Opp 2 Risk 2 | Thesis: Antaris may have strategic opportunity based on the membership rationale referencing private space software work, LEO ISR/optical communications architecture, a JANUS-2 mission, and self-healing satellite capability for the U.S. Space Force, but the reviewed sources includes no retained recent evidence window-window evidence to support scoring that thesis now. Why now: There is no retained 90-day evidence in these reviewed sources despite references to evidence in earlier processing. Recency-sensitive conclusions therefore cannot be made from the local reviewed sources. Caveats: Membership rationale references older evidence but no article IDs are provided with accessible summaries in these reviewed sources body. No representative articles or retained evidence are included. Low score reflects evidence absence, not a negative business judgment. |
| 162 | Antaris Inc. lowweak | Opp 2 Risk 1 | Thesis: There is a faint opportunity signal because the phase2 rationale states Antaris appeared as part of an investment issuer's portfolio after a $28 million Series A, which suggests access to capital, but the reviewed sources does not provide the underlying citable event text in the scoring evidence fields. Why now: Why now is weak: the only reviewed sources signal is the phase2 rationale mentioning a post-Series A portfolio reference tied to article, but no representative article summary or direct evidence row is included here to establish timing or business impact. Caveats: The cited Series A context appears only in phase2 rationale rather than in stronger scoring evidence fields. No product, customer, or execution evidence is provided. |
| 163 | Applied Atomics lowweak | Opp 2 Risk 3 | Thesis: Applied Atomics may have long-horizon optionality as a startup developing in-space mobility/orbital logistics concepts, but the reviewed sources provide no available article or evidence inside the recent evidence window to support a stronger opportunity score. Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak. Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources. |
| 164 | Astranis Space Technologies lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale states Astranis was selected by the U.S. Space Force for the Andromeda contract for next-generation space domain awareness/surveillance satellites, which would be positive if current and retained, but the present reviewed sources contain no in-window evidence to substantiate it. Why now: The current batch retains no representative articles or evidence within the 90-day recent evidence window for Astranis, so the reviewed sources does not provide a current dated catalyst despite the phase-2 rationale. Caveats: No retained evidence after recent evidence window. Phase-2 rationale mentions duplicate article versions; duplicates would not be independent confirmation anyway. |
| 165 | Astrobotic Technology lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Astrobotic operates the Griffin lunar lander and is a CLPS contractor, which is strategically relevant for a 1 year+ horizon, but the reviewed sources supplies no available within the recent evidence window direct positive evidence or dated article summaries for scoring. Why now: The rationale references articles, and: but no corresponding available evidence remains available for direct scoring after recent evidence filtering. Caveats: Lunar lander category fit does not equal thesis attractiveness. Coverage debug shows zero available evidence after recent evidence window. Without direct execution, funding, contract-conversion, or mission-status evidence, scores should remain conservative. |
| 166 | Astrolight lowweak | Opp 2 Risk 1 | Thesis: Membership rationale indicates Astrolight is a private space/defense startup developing laser communication terminals for space, with ESA contracts and deployed terminals, which could support a 1 year+ growth thesis in optical communications if verified by direct evidence. Why now: Why now is weak because the reviewed sources cites support article: in membership rationale, but no, article summary, or retained evidence are provided after the 90-day filter. Caveats: Potentially strong fundamentals are only referenced in membership rationale without citable article details. Coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window. Private-company status also limits external validation in these reviewed sources. |
| 167 | Astrolight UAB lowweak | Opp 2 Risk 2 | Thesis: Astrolight UAB may have a long-horizon opportunity if it is providing optical hardware into a Kepler Communications ESA HydRON optical communications network effort, but the reviewed sources lack available direct evidence to confirm Astrolight's own contract position, scope, or recency. Why now: There is no usable 'why now' beyond possible strategic relevance to optical communications. The reviewed sources provide no after-recent evidence window evidence to confirm current status. Caveats: Phase-2 rationale references, but the reviewed sources does not include its or article summary. Relations marked context-only cannot be used as counterparty propagation evidence. Coverage debug shows zero evidence after recent evidence window. |
| 168 | Astrome lowweak | Opp 2 Risk 1 | Thesis: Reviewed evidence rationale says Astrome was among spacetech startups receiving India's RDI fund support, which is directionally positive as non-dilutive or supportive capital context, but no underlying article or dated event evidence is present in the available recent evidence window dataset. Why now: Why now is weak because the support exists only in the phase-2 rationale; coverage data shows zero evidence after recent evidence window, so timing and durability of the funding support cannot be verified from local evidence. Caveats: No direct article or event evidence is available after recent evidence window. Government-support statement is not accompanied by a dated in-window source in the reviewed sources. Low confidence due to sparse evidence. |
| 169 | Atomos Space lowweak | Opp 2 Risk 1 | Thesis: A very modest opportunity case exists only because retained undated supporting context lists Atomos Space as an operating in-orbit servicing company, which at least suggests ongoing activity in a strategically relevant segment, but this is supporting article context rather than direct company event evidence. Why now: Why now is limited and recency is uncertain: the only retained evidence is undated supporting context, so it cannot establish a fresh catalyst, only background relevance, article date_basis: undated). Evidence
Caveats: The evidence is undated, and the reviewed sources explicitly says to treat undated external evidence as relevance context rather than recency proof. The retained rows are weak context and neutral polarity, not positive evidence. Same article repeated rows are not independent confirmation. |
| 170 | Azista Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Azista Space built the satellite bus/payload for GalaxEye's Drishti Earth Observation Satellite, which implies real manufacturing participation and possible long-horizon opportunity, but no direct evidence or article are available in the served reviewed sources. Why now: Why now is weak because there is no surviving 90-day evidence row in the reviewed sources to establish recency or momentum. Caveats: Only membership rationale is available; no citeable direct evidence with are provided. Single-article universe increases fragility of inference. |
| 171 | Blackstar Orbital lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale suggests Blackstar Orbital is described as a hypersonic/reusable spacecraft testing partner with mention of a reusable hypersonic satellite concept, which could imply technology optionality if substantiated and, no provided in reviewed sources). However, the evidence retained here is not direct and no positive events are available after recent evidence window. Why now: No near-term or durable catalyst can be established from retained evidence because coverage debug shows zero article IDs and zero evidence after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. The reviewed sources explicitly characterizes the evidence as mostly partnership context rather than direct operating detail. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 172 | Brightside Group S.A. lowweak | Opp 2 Risk 2 | Thesis: Membership rationale indicates Brightside is advancing a €415M sovereign satellite program and provides a sovereign satellite platform via partnership with SES, which could be meaningful if current, but the reviewed sources exposes no direct within the recent evidence window evidence or article summaries to substantiate a current opportunity thesis. Why now: Why now is weak because no representative article or direct evidence survives in the ranking fields after recent evidence window; only membership rationale references without surfaced article content. Caveats: No direct within the recent evidence window evidence is available in ranking fields. Membership rationale alone is weaker than surfaced company-specific event evidence. No negative thesis is supportable from the reviewed sources. |
| 173 | BULL Co., Ltd. lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says BULL signed an agreement with Fujitsu to develop a high-precision space situational awareness service for Japan, which is directionally positive, but there is no retained within the recent evidence window article evidence or in the reviewed sources to support a stronger opportunity thesis. Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context. Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources. |
| 174 | Calian Group Ltd. lowweak | Opp 2 Risk 1 | Thesis: There is some older membership support that the Canadian Space Agency awarded Calian funds for RADARSAT+ ground-segment concept studies via article: which could indicate space-contract relevance, but no retained in-window evidence with supports a stronger current opportunity thesis. Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced. Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation. |
| 175 | CAS Space lowweak | Opp 2 Risk 3 | Thesis: CAS Space may have long-horizon opportunity as a reusable rocket developer and launch provider, but the ranking reviewed sources provide no available supporting evidence within the recent evidence window. Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst. Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources. |
| 176 | CAS Space lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says CAS Space is among Chinese rocket/satellite companies advancing IPO or pre-IPO plans, which could be a strategic opportunity signal if supported by company-specific evidence (: and: no provided in reviewed sources). Why now: There is no verified current catalyst in retained evidence. IPO/pre-IPO framing could matter on a 1 year+ horizon, but recency and milestone state cannot be confirmed here because no dated evidence are available after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. IPO/pre-IPO mention is only in reviewed sources rationale, not in retained direct evidence. |
| 177 | Citra Space Corp lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says Citra Space raised a $15M Series A to advance space object identification technology, which would ordinarily be positive, but the reviewed sources provide no retained within the recent evidence window article evidence or to ground a stronger opportunity call. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative. Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness. |
| 178 | Cosmoserve Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Cosmoserve Space is a private space sustainability company working on debris removal, with Pixxel providing a satellite bus for its demo mission. That suggests a real mission path, but there are no citeable direct evidence or in the served reviewed sources. Why now: Why now is weak because the reviewed sources does not establish current demo timing or funding status with direct evidence after recent evidence window. Caveats: Private company with thin visible evidence in these reviewed sources. Mission/demo status cannot be validated from available evidence. |
| 179 | Curtiss-Wright Corporation lowweak | Opp 2 Risk 1 | Thesis: Curtiss-Wright has modest contextual opportunity because the membership rationale describes it as a ruggedized electronics supplier benefiting from broader space spending, which could align with a durable 1 year+ strategic cycle if backed by company-specific orders or segment growth evidence (: unavailable in reviewed sources). But the reviewed sources contain no direct positive evidence within the recent evidence window. Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated. Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered. |
| 180 | Deloitte lowweak | Opp 2 Risk 1 | Thesis: There is some indication of meaningful space activity, but not enough retained direct evidence to make a strong 1 year+ opportunity call. Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence. Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested. |
Risk view
Showing rows 261-280 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 261 | Axiom Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present in the reviewed sources. Risk score remains low because absence of current evidence is not itself a negative thesis. Why now: There is no within the recent evidence window catalyst in the available evidence. The only cited context is an older article with September 2, 2025, outside the 90-day evidence window Caveats: Coverage after recent evidence window is effectively empty: evidence after recent evidence window is 0. Older supporting context exists but was excluded by the 90-day recent evidence window. No direct positive or negative evidence is available. |
| 262 | Axiom Space Inc. lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis is supportable because the reviewed sources provide no direct negative evidence in the final evidence fields. Why now: The phase2 rationale says Axiom was mentioned in connection with a lunar suit presentation and an orbital data center feature, but those article details are not surfaced in citable evidence here. Coverage data shows zero articles after recent evidence window and zero available evidence, so there is no current catalyst basis in the reviewed sources. Caveats: Phase2 rationale is weaker than direct event/fact evidence. No dated current-state evidence is available in the scoring fields. |
| 263 | BAE Systems plc lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available for BAE Systems in this screen. Risk score stays low only because evidence is missing, not because the company is affirmatively de-risked. Why now: Why-now is weak because the reviewed sources show no reviewed evidence after recent evidence window despite many articles considered, leaving no admissible dated evidence in the current output batch. Caveats: Membership rationale references, and, but no article summaries or evidence are provided here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Broad-company membership in a cohort is not itself a directional opportunity thesis. |
| 264 | Baykar lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable because the retained reviewed sources provide no direct negative evidence within the recent evidence window. Why now: Why now is weak: there are no retained evidence after recent evidence window, and the reviewed sources' membership rationale is based only on weak indirect article context. Caveats: Phase-2 membership rationale cites and says Fergani Space was described as 'Baykar affiliated,' but no article summary or quote is available in the retained reviewed sources for factual use here. The reviewed sources itself characterizes the evidence as weak, indirect article context. |
| 265 | Beyond Gravity lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis can be supported from these reviewed sources because no direct negative evidence survived the 90-day recent evidence window. Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent. Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent. |
| 266 | Blackstar Orbital lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct negative evidence, so there is no supportable risk thesis. Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided. Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources. |
| 267 | Bluestaq lowweak | Opp 0 Risk 1 | Thesis: No material adverse evidence is shown either. The low risk score reflects absence of documented negative evidence, but the company remains unrankable on fundamentals from these reviewed sources. Why now: There is no clear why-now catalyst because the only reference is an indirect executive-background mention, with no direct event, product, contract, or financing evidence available. Caveats: No current evidence is provided for Indirect mention via an executive's prior role is not direct company evidence. Zero evidence available after recent evidence window. |
| 268 | BULL Co., Ltd. lowweak | Opp 2 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided. Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context. Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources. |
| 269 | Calian Group Ltd. lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available, so there is no supported adverse thesis beyond normal uncertainty from lack of recent evidence. Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced. Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation. |
| 270 | Canada Rocket Company lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources within the recent evidence window, so there is no supported negative thesis beyond generic execution risk, which cannot be used without company-specific evidence. Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen. Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence. |
| 271 | Canon Inc. lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no reviewed sources basis for a material risk thesis. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context. |
| 272 | Capella Space lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is retained either, so a risk thesis is not supported on this slice. Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent. Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used. |
| 273 | China Aerospace Science and Technology Corporation lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not load any direct negative evidence within the 90-day recent evidence window, so no risk thesis is supported. Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources. Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 274 | China Rocket lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient direct negative evidence for a risk thesis. Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window. Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available. |
| 275 | China Spacesat lowweak | Opp 1 Risk 1 | Thesis: There is no retained adverse evidence specific to China Spacesat, so a risk thesis is unsupported. Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window. Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence. |
| 276 | Chunghwa Telecom Co., Ltd. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable from the retained reviewed sources evidence because there is no direct negative evidence after recent evidence window. Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided. Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company. |
| 277 | CITIC Group lowweak | Opp 0 Risk 1 | Thesis: No material direct negative evidence is available, but ambiguity and possible spurious matching elevate watchlist risk slightly. Why now: There is no current catalyst. Despite 4,475 article IDs considered, the reviewed sources reports zero article IDs after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article IDs: and: as context, but no were provided in the reviewed sources. Very large raw mention universe does not imply conviction or thesis attractiveness. Possible name/alias ambiguity is unresolved by the reviewed sources. |
| 278 | Citra Space Corp lowweak | Opp 2 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided, so there is no basis for a strong risk thesis. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative. Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness. |
| 279 | Clear Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present. Ranking remains low on risk because the reviewed sources does not document a negative catalyst. Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources. Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed. |
| 280 | Collins lowweak | Opp 1 Risk 1 | Thesis: Entity-identity ambiguity is the main risk in these reviewed sources; there is no available material adverse evidence specific to Collins after recent evidence filtering. Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or. Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered. |